Human Immunodeficiency Virus Infection
📧 Sign up to get email alerts when something new happens for Human Immunodeficiency Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-04-12Clinical Trial Update: Improving HIV and Alcohol-Related Outcomes Among HIV+ Persons in Clinic Settings [NA]
A completed clinical trial evaluating HIV and alcohol-related outcomes in HIV-positive individuals in clinic settings; results posted in 202…
-
CLINICAL_TRIALS trial_result · 2020-12-29Clinical Trial Update: Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study [Phase 2]
Phase 2 trial comparing statin versus aspirin treatment intervention in HIV+ individuals on ART, completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-24Clinical Trial Update: Effect of Evolocumab on Coronary Endothelial Function [Phase 2]
Phase 2 clinical trial evaluating evolocumab's effect on coronary endothelial function in adults with HIV and coronary artery disease has co…
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: CHAMPS Study: Chronic HepAtitis C Management to ImProve OutcomeS [NA]
A completed CHAMPS study investigating chronic hepatitis C management to improve outcomes, with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-24Clinical Trial Update: Atazanavir/r + Lamivudine Dual Therapy [Phase 4]
Phase 4 clinical trial update of Atazanavir/ritonavir plus Lamivudine as dual therapy for HIV has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-07-08Clinical Trial Update: Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV [Phase 3]
Phase 3 trial of grazoprevir/elbasvir for acute hepatitis C in people with HIV has completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected Adults [Phase 2]
Phase 2 safety and efficacy study of GSK2838232 in adults infected with HIV-1 has completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-22Clinical Trial Update: An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2) [Phase 3]
Phase 3 Gemini 2 trial compared dolutegravir with lamivudine against dolutegravir with tenofovir/emtricitabine in treatment-naïve HIV patien…
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection [Phase 3]
Completed Phase 3 open-label study comparing dolutegravir and efavirenz for HIV/TB co-infection; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Sofosbuvir and Daclatasvir for Treating Hepatitis C in 200 Patients Co-infected With Human Immunodeficiency Virus [Phase 3]
A Phase 3 trial evaluating sofosbuvir and daclatasvir for hepatitis C in 200 patients co-infected with HIV has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Education vs Education Plus Intervention in HIV/HCV Diagnosis (DRIVE 03) [NA]
A completed clinical trial compares education alone to education plus intervention for diagnosing HIV and hepatitis C virus coinfection.
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy Subjects [Phase 1]
Phase 1 study evaluating how rifabutin affects the pharmacokinetics of oral cabotegravir in healthy subjects.
-
CLINICAL_TRIALS trial_result · 2018-11-29Clinical Trial Update: Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults. [Phase 2]
Phase 2 safety and tolerability study evaluating a lower dose of GSK2248761 in antiretroviral-treatment-naive HIV-1 infected adults complete…
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections [Phase 2]
Phase 2 clinical trial update for an HIV attachment inhibitor intended to treat HIV-1 infections; results have been posted with completion i…
-
CLINICAL_TRIALS trial_result · 2018-10-23Clinical Trial Update: Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018) [Phase 3]
Phase 3 study results update for Doravirine (MK-1439) in HIV-1 infection, reporting safety and efficacy data with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-12Clinical Trial Update: Early Simplified: A Trial to Compare the Efficacy of Standard of Care Combination Antiretroviral Therapy With a Simplified Dolutegravir Monotherapy in Patients With a Primary HIV-1 Infection [Phase 2]
A Phase 2 trial comparing standard combination ART to dolutegravir monotherapy in patients with primary HIV infection; current status is unk…
-
CLINICAL_TRIALS trial_result · 2018-10-09Clinical Trial Update: Get Ready And Empowered About Treatment [NA]
Clinical trial completed with results posted for an HIV study conducted by the University of Rochester.
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: Switch to Unboosted Atazanavir With Tenofovir Study [Phase 4]
A Phase 4 study evaluated switching to unboosted atazanavir with tenofovir in HIV infection; results have been posted after study completion…
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: HIV in Orthopaedic Skeletal Trauma Study
Clinical trial update on fracture healing in HIV-positive patients; no status or results are provided in the snippet.
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2) [Phase 3]
Phase 3 trial EXPEDITION-2 evaluated ABT-493/ABT-530 for efficacy and safety in adults with chronic hepatitis C virus genotype 1-6 infection…
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: Comparison of Doravirine, Tenofovir, Lamivudine (MK-1439A) and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439A-021) [Phase 3]
Phase 3 clinical trial update comparing doravirine/tenofovir disoproxil fumarate/lamivudine (MK-1439A-021) with ATRIPLA in treatment-naive H…
-
CLINICAL_TRIALS trial_result · 2018-04-23Clinical Trial Update: Niacin on Immune Activation : a Proof-of-concept Study [Phase 2]
Phase 2 proof-of-concept trial evaluating niacin for immune activation in people with HIV; the study has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: 3BNC117 and 10-1074 in HIV Uninfected Adults [Phase 1]
A Phase 1 trial evaluated the safety and pharmacokinetics of two broadly neutralizing HIV antibodies, 3BNC117 and 10-1074, in HIV-uninfected…
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: A Safety and Immunogenicity Study of 3 Doses of Opal Immunotherapy in HIV Infected People [Phase 1]
Phase 1 safety and immunogenicity data were collected for three doses of Opal Immunotherapy in people with HIV infection, but the study was …
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: Pharmacokinetic Study of the Dapivirine Vaginal Ring in Lactating Women [Phase 1]
Phase 1 pharmacokinetic study of the dapivirine vaginal ring in lactating women has completed.